All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, March 5, 2021
Home » Blogs » BioWorld MedTech Perspectives » A journey through Ontario's life sciences

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

A journey through Ontario's life sciences

July 9, 2013
By Amanda Pedersen
No Comments

 

A researcher with Interface Biologics works in the company's lab. The company develops polymers additives and drug delivery devices.
A researcher with Interface Biologics works in the company's lab. The company develops polymers additives and drug delivery devices.

Writing about medical devices on a daily basis without ever seeing the inside of a life sciences laboratory or a healthcare facility would be a bit like a sports writer who never steps foot inside a stadium. And yet many of us journalists rarely get the opportunity to see where all the magic happens in the industries we cover so faithfully. Recently I had an opportunity, for the second time, to visit nearly a dozen life sciences facilities during a four-day tour of Ontario’s medical device industry which included stops in both Toronto and Ottawa. The tour, organized by the Ontario Ministry of Economic Development Trade and Employment, included journalists from seven different countries around the globe. I participated in a similar tour of the province in November 2011 and was grateful for the opportunity to visit Ontario’s medical device industry again in June. Appropriately, the tour began in a truly unique facility in the heart of Toronto’s life sciences research community, an innovation center dubbed the MaRS Discovery District. Built with the intention of bringing together researchers and entrepreneurs to collaborate on new life sciences technologies, MaRS is home to 140 tenants, 80 of which are start-ups, and is set up to accommodate both executive offices and laboratory facilities, often located just a few steps from one another. During the first day of the tour, Minister Reza Moridi of the Ontario Ministry of Research and Innovation told us that Ontario sees innovative research as a journey. And indeed, after four long days of visiting companies and research facilities in Toronto and Ottawa, it certainly felt like we had been on quite a journey. I think I was the only one in the group who got really excited the first time we were asked to slip into a white lab coat and safety goggles before walking through a lab, it was the first time I felt like I was dressing up like a scientist! By the fourth or fifth lab we visited, the luster of the white lab coat had worn off, but it was still neat to see researchers hard at work trying to advance the field of medicine.

And in Canada’s capital, where people from all over the country were gathering to celebrate Canada Day on July 1, we got to see the opposite end of the innovation spectrum, the manufacturing facility of Best Theratronics, where welders and other plant workers were building cyclotron systems for research and radioisotope production, external beam therapy units for cancer therapy, and self-contained irradiators for blood and research purposes.

[caption id="attachment_2591" align="alignleft" width="150"]Richard Wassenaar, PhD, of Best Theratronics shows journalists the company's Cyclotron systems Richard Wassenaar, PhD, of Best Theratronics shows journalists the company's Cyclotron systems[/caption]

Most impressive at the Best Theratronics stop was the 70 MeV Cyclotron. Over the past few years the company has had to upgrade a 5,900 square foot dedicated room in order to build such a massive machine in-house.

All in all the tour provided us with a comprehensive picture of Ontario’s medical device industry and the take-home message was quite clear, the life sciences are important to Ontario.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 4.
  • Gloved hand places sample tubes in PCR system

    COVID-19 test makers are adapting for variants

    BioWorld MedTech
    As COVID-19 variants have emerged, so have questions about the effectiveness of tests for infection. While the risk of mutations significantly limiting their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for March 4.
  • Celltrion-Regkirona-2-9

    Celltrion wins first conditional Korean approval for COVID-19 antibody Regkirona

    BioWorld
    HONG KONG – Celltrion Inc. has received conditional marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its anti-COVID-19 monoclonal...
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing